FDA pol­i­cy change opens the door for abor­tion pill in phar­ma­cies

The FDA will now al­low cer­tain phar­ma­cies to dis­pense mifepri­s­tone, a pill used in com­bi­na­tion with an­oth­er med­i­cine, to end ear­ly preg­nan­cies.

Af­ter con­duct­ing a “com­pre­hen­sive re­view” of mifepri­s­tone’s risk eval­u­a­tion and mit­i­ga­tion strat­e­gy (REMS) — which pre­vi­ous­ly re­quired pa­tients to re­ceive the drug in a clin­ic, med­ical of­fice or hos­pi­tal — the agency on Tues­day ap­proved a mod­i­fi­ca­tion that per­mits cer­ti­fied phar­ma­cies to sell Dan­co Lab’s brand-name Mifeprex pills and a gener­ic man­u­fac­tured by Gen­Bio­Pro.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER